Suppr超能文献

新型冠状病毒肺炎与甲状腺——进展与展望。

Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives.

机构信息

The First Department of Medicine, Wakayama Medical University, Wakayama, Japan.

Department of Diabetes, Endocrinology, and Metabolism, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.

出版信息

Front Endocrinol (Lausanne). 2021 Jun 24;12:708333. doi: 10.3389/fendo.2021.708333. eCollection 2021.

Abstract

SARS-CoV-2 infection (COVID-19) is currently a tremendous global health problem. COVID-19 causes considerable damage to a wide range of vital organs most prominently the respiratory system. Recently, clinical evidence for thyroidal insults during and after COVID-19 has been accumulated. As of today, almost all non-neoplastic thyroid diseases, i.e., Graves' disease, Hashimoto's thyroiditis, subacute, painless and postpartum thyroiditis, have been reported as a complication of COVID-19, and causality by the virus has been strongly implicated in all of them. Similar thyroid problems have been reported in the past with the SARS-CoV outbreak in 2002. In this review, we briefly look back at the reported evidence of alteration in thyroid functionality and thyroid diseases associated with SARS-CoV and then proceed to examine the issue with COVID-19 in detail, which is then followed by an in-depth discussion regarding a pathogenetic link between Coronavirus infection and thyroid disease.

摘要

SARS-CoV-2 感染(COVID-19)目前是一个巨大的全球健康问题。COVID-19 对广泛的重要器官造成了相当大的损害,最突出的是呼吸系统。最近,COVID-19 期间和之后甲状腺损伤的临床证据已经积累。截至今天,几乎所有的非肿瘤性甲状腺疾病,即格雷夫斯病、桥本甲状腺炎、亚急性、无痛性和产后甲状腺炎,都被报道为 COVID-19 的并发症,而且病毒的因果关系在所有这些疾病中都被强烈暗示。过去在 2002 年 SARS-CoV 爆发时也有类似的甲状腺问题报道。在这篇综述中,我们简要回顾了与 SARS-CoV 相关的甲状腺功能改变和甲状腺疾病的报道证据,然后详细研究了 COVID-19 的问题,随后深入讨论了冠状病毒感染和甲状腺疾病之间的发病机制联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/958e/8279745/90a5fbbe9a5b/fendo-12-708333-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验